LADYBARN GROUP PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: P84017 | MANCHESTER, M20 4SS
Showing results 51-100 of 637
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Fexofenadine hydrochloride | 1,124 | 42.3K | £1.8K | +32.2% ▲ |
| Docusate sodium | 1,034 | 78.1K | £5.6K | +178.9% ▲ |
| Hydrocortisone | 1,025 | 34.1K | £5.6K | +128.6% ▲ |
| Losartan potassium | 990 | 31.2K | £828 | -44.1% ▼ |
| Montelukast | 989 | 29.5K | £1.3K | +44.4% ▲ |
| Thiamine hydrochloride | 988 | 49.9K | £1.2K | +87.4% ▲ |
| Doxazosin mesilate | 962 | 38.0K | £1.7K | -9.9% ▼ |
| Allopurinol | 958 | 43.2K | £946 | -7.1% ▼ |
| 897 | 911 | £40.5K | +188.8% ▲ | |
| Famotidine | 887 | 29.2K | £15.9K | +81.8% ▲ |
| Buprenorphine | 865 | 5,754 | £19.2K | +136.1% ▲ |
| Amoxicillin | 839 | 34.6K | £988 | -10.0% ▼ |
| Ferrous sulfate | 834 | 38.7K | £1.7K | +62.2% ▲ |
| Progesterone | 830 | 48.1K | £9.8K | +98.3% ▲ |
| Mometasone furoate | 828 | 840 | £6.5K | +106.2% ▲ |
| Hydroxocobalamin | 819 | 847 | £1.8K | +70.2% ▲ |
| Codeine phosphate | 799 | 68.3K | £2.4K | +11.2% ▲ |
| Rivaroxaban | 790 | 22.0K | £13.9K | +29.1% ▲ |
| Aripiprazole | 783 | 18.6K | £2.4K | +207.7% ▲ |
| Insulin aspart | 773 | 4,401 | £29.2K | +103.0% ▲ |
| 768 | 7,985 | £2.1K | +267.5% ▲ | |
| Prednisolone | 761 | 34.8K | £1.3K | -4.8% ▼ |
| 758 | 10.4K | £7.7K | +14.1% ▲ | |
| Isosorbide mononitrate | 757 | 23.3K | £4.2K | +14.5% ▲ |
| 751 | 96.3K | £3.6K | +58.3% ▲ | |
| Mirabegron | 737 | 17.8K | £16.4K | +83.5% ▲ |
| 723 | 1,471 | £51.5K | +32.6% ▲ | |
| Levetiracetam | 718 | 68.3K | £4.4K | +56.8% ▲ |
| Fluticasone propionate (Inhalation) | 704 | 775 | £16.6K | +81.9% ▲ |
| Olanzapine | 703 | 13.9K | £1.8K | +89.8% ▲ |
| Hyoscine butylbromide | 697 | 60.8K | £4.2K | +199.1% ▲ |
| Sildenafil (Erectile Dysfunction) | 689 | 4,924 | £685 | +36.7% ▲ |
| Carbocisteine | 677 | 96.0K | £3.3K | +26.8% ▲ |
| Fluticasone furoate/vilanterol | 667 | 736 | £17.0K | +330.8% ▲ |
| Ezetimibe | 642 | 21.3K | £3.7K | -9.8% ▼ |
| Finasteride | 641 | 16.6K | £791 | -2.1% ▼ |
| Canagliflozin | 636 | 24.8K | £30.9K | +343.0% ▲ |
| 635 | 75.8K | £2.3K | +129.7% ▲ | |
| Indapamide | 634 | 23.0K | £963 | -26.5% ▼ |
| Zopiclone | 619 | 9,625 | £423 | +11.8% ▲ |
| Ferrous fumarate | 604 | 32.0K | £1.2K | -16.7% ▼ |
| Fluticasone/umeclidinium/vilanterol | 600 | 623 | £26.3K | +155.9% ▲ |
| Hypromellose | 595 | 7,060 | £2.3K | +349.0% ▲ |
| Bendroflumethiazide | 585 | 20.0K | £336 | -24.4% ▼ |
| Semaglutide | 583 | 13.5K | £49.3K | +142.1% ▲ |
| Nifedipine | 580 | 21.7K | £4.7K | +209.5% ▲ |
| Nitrofurantoin | 576 | 6,466 | £3.3K | +20.7% ▲ |
| Estriol | 568 | 6,047 | £11.7K | +166.9% ▲ |
| Oxycodone hydrochloride | 551 | 47.0K | £4.6K | +115.3% ▲ |
| Betamethasone valerate | 550 | 46.8K | £2.3K | +42.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.